{"id":"NCT01605227","sponsor":"Exelixis","briefTitle":"Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100","officialTitle":"A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) Versus Prednisone in Metastatic Castration-resistant Prostate Cancer Patients Who Have Received Prior Docetaxel and Prior Abiraterone or MDV3100","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2014-09","completion":"2015-03","firstPosted":"2012-05-24","resultsPosted":"2018-03-14","lastUpdate":"2018-03-14"},"enrollment":1028,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer","Castration Resistant Prostate Cancer","Pain","Prostatic Neoplasms"],"interventions":[{"type":"DRUG","name":"cabozantinib","otherNames":["XL184"]},{"type":"DRUG","name":"prednisone","otherNames":[]}],"arms":[{"label":"cabozantinib","type":"EXPERIMENTAL"},{"label":"prednisone","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with bone-dominant disease who have experienced disease progression on docetaxel-containing chemotherapy and abiraterone or MDV3100.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"OS was measured from the time of randomization until 614 events, approximately 24 months after study start","effectByArm":[{"arm":"Cabozantinib","deltaMin":11,"sd":null},{"arm":"Prednisone","deltaMin":9.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.213"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":13},"locations":{"siteCount":264,"countries":["United States","Australia","Austria","Belgium","Canada","France","Germany","Ireland","Italy","Netherlands","Puerto Rico","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["29272162","27400947"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":420,"n":681},"commonTop":["Decreased appetite","Nausea","Fatigue","Diarrhoea","Vomiting"]}}